Kurt J. Isselbacher

27.2k total citations · 4 hit papers
324 papers, 20.2k citations indexed

About

Kurt J. Isselbacher is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Kurt J. Isselbacher has authored 324 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 55 papers in Surgery and 50 papers in Epidemiology. Recurrent topics in Kurt J. Isselbacher's work include Metabolism and Genetic Disorders (38 papers), Amino Acid Enzymes and Metabolism (34 papers) and Glycosylation and Glycoproteins Research (30 papers). Kurt J. Isselbacher is often cited by papers focused on Metabolism and Genetic Disorders (38 papers), Amino Acid Enzymes and Metabolism (34 papers) and Glycosylation and Glycoproteins Research (30 papers). Kurt J. Isselbacher collaborates with scholars based in United States, Israel and Australia. Kurt J. Isselbacher's co-authors include Jack R. Wands, W. Allan Walker, Elliot Alpert, Joseph L. Perrotto, Daniel K. Podolsky, Toshi Shioda, Daniel A. Haber, Seymour M. Sabesin, John Senior and Ulrich Hopfer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Kurt J. Isselbacher

316 papers receiving 17.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

2005 774 citations Eunice L. Kwak, Raffaella Sordella et al. Proceedings of the National Academy of Sciences profile →
Glucose Transport in Isolated Brush Border Membrane from Rat Small Intestine

1973 759 citations Ulrich Hopfer, Kurt J. Isselbacher et al. Journal of Biological Chemistry profile →
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

1999 662 citations Daphne W. Bell, Kurt J. Isselbacher et al. profile →
Rat intestinal microvillus membranes. Purification and biochemical characterization

1968 406 citations Kurt J. Isselbacher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kurt J. Isselbacher United States	79	7.9k	3.4k	3.1k	2.9k	2.8k	324	20.2k
Stephen M. Prescott United States	89	9.1k 1.2×	2.3k 0.7×	2.5k 0.8×	4.8k 1.7×	2.3k 0.8×	233	25.6k
Sheldon Wolff United States	69	7.3k 0.9×	1.7k 0.5×	1.5k 0.5×	2.6k 0.9×	1.6k 0.6×	235	23.9k
Thomas M. McIntyre United States	89	10.1k 1.3×	1.9k 0.6×	1.8k 0.6×	3.7k 1.3×	3.1k 1.1×	240	26.2k
Lisa H. Underhill United States	42	4.4k 0.6×	2.6k 0.8×	2.3k 0.7×	2.7k 0.9×	1.2k 0.4×	60	16.8k
Guy A. Zimmerman United States	98	10.5k 1.3×	2.5k 0.7×	2.1k 0.7×	3.9k 1.4×	3.7k 1.3×	262	32.6k
Fumimaro Takaku Japan	68	8.8k 1.1×	3.3k 1.0×	2.0k 0.6×	2.1k 0.7×	1.4k 0.5×	657	20.9k
Andrew J. Dannenberg United States	86	7.8k 1.0×	5.6k 1.7×	4.9k 1.6×	2.7k 1.0×	2.8k 1.0×	273	24.3k
David W. Golde United States	74	4.8k 0.6×	2.7k 0.8×	1.8k 0.6×	766 0.3×	1.2k 0.4×	257	19.1k
John S. Parks United States	68	6.8k 0.9×	2.2k 0.6×	2.3k 0.7×	6.9k 2.4×	2.0k 0.7×	330	17.9k
Burkhard Göke Germany	72	6.0k 0.8×	4.1k 1.2×	3.2k 1.0×	6.1k 2.1×	3.6k 1.3×	423	20.1k

Countries citing papers authored by Kurt J. Isselbacher

Since Specialization

Citations

This map shows the geographic impact of Kurt J. Isselbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt J. Isselbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt J. Isselbacher more than expected).

Fields of papers citing papers by Kurt J. Isselbacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt J. Isselbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt J. Isselbacher. The network helps show where Kurt J. Isselbacher may publish in the future.

Co-authorship network of co-authors of Kurt J. Isselbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt J. Isselbacher. A scholar is included among the top collaborators of Kurt J. Isselbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt J. Isselbacher. Kurt J. Isselbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shioda, Keiko, et al.. (2019). Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells. Journal of Visualized Experiments. 2 indexed citations

Kwak, Eunice L., Raffaella Sordella, Daphne W. Bell, et al.. (2005). Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proceedings of the National Academy of Sciences. 102(21). 7665–7670. 774 indexed citations breakdown →

Isselbacher, Kurt J.. (2005). GASTROINTENSTINAL DISEASE: Irritable bowel syndrome: the possible benefits of probiotics. Postgraduate Medicine. 117(5). 7–7. 2 indexed citations

Yahata, Tetsuro, Mark P. de Caestecker, Robert J. Lechleider, et al.. (2000). The MSG1 Non-DNA-binding Transactivator Binds to the p300/CBP Coactivators, Enhancing Their Functional Link to the Smad Transcription Factors. Journal of Biological Chemistry. 275(12). 8825–8834. 110 indexed citations

Shafman, Timothy D., Asa J. Nixon, Seth Levitz, et al.. (1998). Prevalence of ataxia-telangiectasia heterozygosity in patients developing contralateral breast cancer following treatment with conservative surgery and radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 42(1). 253–253. 1 indexed citations

Ishioka, Chikashi, Takao Suzuki, Michael G. FitzGerald, et al.. (1997). Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proceedings of the National Academy of Sciences. 94(6). 2449–2453. 44 indexed citations

Englert, Christoph, Marc Vidal, Shyamala Maheswaran, et al.. (1995). Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.. Proceedings of the National Academy of Sciences. 92(26). 11960–11964. 127 indexed citations

Gattoni‐Celli, Sebastiano, et al.. (1990). Partial Suppression of Metastatic Potential of Malignant Cells in Immunodeficient Mice Caused by Transfection of H-2Kb Gene. JNCI Journal of the National Cancer Institute. 82(11). 960–963. 7 indexed citations

Isselbacher, Kurt J.. (1984). Medicine, science, and society : symposia celebrating the Harvard Medical School bicentennial. Wiley eBooks. 9 indexed citations

10.

Bellet, Dominique, Jack R. Wands, Kurt J. Isselbacher, & Claude Bohuon. (1984). Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay.. Proceedings of the National Academy of Sciences. 81(12). 3869–3873. 63 indexed citations

11.

Tillotson, Loyal G., Edward A. Carter, Ken‐ichi Inui, & Kurt J. Isselbacher. (1981). Inhibition of Na+-stimulated glucose transport function and perturbation of intestinal microvillus membrane vesicles by ethanol and acetaldehyde. Archives of Biochemistry and Biophysics. 207(2). 360–370. 32 indexed citations

12.

Powell, L. W., J. Thomas LaMont, & Kurt J. Isselbacher. (1974). Haemolysis in experimental cholestasis: Possible role of erythrocyte sialic acid. Gut. 15(10). 794–798. 9 indexed citations

13.

Isselbacher, Kurt J., et al.. (1973). Effect of different media supplements on amino acid uptake and mitotic stimulation in BHK cells.. PubMed. 243(124). 83–5. 11 indexed citations

14.

Hopfer, Ulrich, et al.. (1972). Specific glucose transport in isolated brush border membranes from rat small intestine. Cellular and Molecular Life Sciences. 28(6). 737. 1 indexed citations

15.

Heizer, W., et al.. (1972). Intestinal peptide hydrolases differences between brush border and cytoplasmic enzymes☆. Biochimica et Biophysica Acta (BBA) - General Subjects. 264(3). 450–461. 68 indexed citations

16.

Isselbacher, Kurt J. & Robert E. Scully. (1967). Case 51-1967. New England Journal of Medicine. 277(24). 1307–1314. 3 indexed citations

17.

Greenberger, Norton J., Francis D. Milligan, Leslie J. DeGroot, & Kurt J. Isselbacher. (1964). Jaundice and thyrotoxicosis in the absence of congestive heart failure. The American Journal of Medicine. 36(6). 840–846. 41 indexed citations

18.

Isselbacher, Kurt J. & Elizabeth A. McCarthy. (1959). STUDIES ON BILIRUBIN SULFATE AND OTHER NONGLUCURONIDE CONJUGATES OF BILIRUBIN†. Journal of Clinical Investigation. 38(4). 645–651. 68 indexed citations

19.

Anderson, Elizabeth P., Herman Μ. Kalckar, Kiyoshi Kurahashi, & Kurt J. Isselbacher. (1957). A specific enzymatic assay for the diagnosis of congenital galactosemia. I. The consumption test.. PubMed. 50(3). 469–77. 84 indexed citations

20.

Anderson, Elizabeth P., H. M. Kalckar, & Kurt J. Isselbacher. (1957). A SPECIFIC ENZYMATIC DEFECT IN CONGENITAL GALACTOSEMIA. Human Heredity. 7(1). 187–188.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact